A FRESH APPROACH
With an expert team and our fresh patient tumor platforms,
Nilogen enables confidence in every step of drug development
A FRESH APPROACH
With an expert team and our fresh patient tumor platforms,
Nilogen enables confidence in every step of drug development
ABOUT NILOGEN
Nilogen is a rapidly growing biotechnology company providing cutting-edge innovative solutions in immuno-oncology drug development and personalized cancer care. With our innovative approach to drug development utilizing fresh patient tumoroids Nilogen performs correlative studies between ex vivo drug responses and multiple aspects of the tumor microenvironment. This translates to faster results and the development of companion diagnostics that can be applied to clinical trials and patient care.
Founded in 2013, Nilogen Oncosystems is based in Tampa, FL where we strive to provide the highest level of service in our CLIA-certified lab.
With years of experience in fresh patient 3D ex vivo systems we provide relevant,
cost-effective solutions for every stage of drug development.
cost-effective solutions for every stage of drug development.
Jenny Kreahling PhD,
Nilogen Oncosystems, Director of Operations
OUR MISSION
Nilogen’s mission is to improve drug development and patient care by providing innovative solutions to the drug development industry. We do this with our fresh patient tissue platforms that maintain an intact tumor microenvironment for more translatable results. This helps reduce the cost of clinical trials by eliminating ineffective drugs earlier and increasing the potential for successful outcomes.
OUR VISION
To improve people’s lives by making drugs more affordable through effective clinical trials and successful personalized cancer care.
OUR VISION
To improve people’s lives by making drugs more affordable through effective clinical trials and successful personalized cancer care.
